| Financial Year |
March 31 2023 |
| Monetary Funds |
1,677,371,056.04 |
| Held-for-trading Financial Assets |
414,256,611.11 |
| Notes Receivable |
75,060,528.81 |
| Accounts Receivable |
1,110,898,221.86 |
| Advances to Suppliers |
390,384,616.34 |
| Other Receivables |
146,719,098.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
987,202,759.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,086,123,924.16 |
| Total Current Assets |
5,913,617,468.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,393,362,847.28 |
| Investment Properties |
2,506,986,603.84 |
| Fixed Assetes |
5,099,098,272.40 |
| Under-construction Projects |
343,994,430.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
621,188,968.20 |
| R&D expenses |
18,553,432.54 |
| Goodwill |
6,754,694,927.52 |
| Long-Term Deferred and Prepaid Expenses |
110,793,384.01 |
| Deferred Income Tax Assets |
524,658,661.22 |
| Other Non-Current Assets |
16,217,349.11 |
| Sub-Total of Non-Current Assets |
18,586,714,134.81 |
| Total Assets |
24,500,331,603.64 |
| Short-Term Loans |
2,745,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
142,680,819.16 |
| Accounts Payable |
726,786,757.74 |
| Accounts Received In Advance |
800,248.95 |
| Employee Compensation Payable |
56,599,994.26 |
| Taxes Payable |
49,152,119.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,865,121.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
287,741,138.86 |
| Other Current Liabilities |
635,625,040.21 |
| Sub-Total of Current Liabilities |
4,863,469,887.87 |
| Long-term Loans |
619,618,964.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
435,769,514.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,197,081,305.08 |
| Total Liabilities |
6,060,551,192.95 |
| Paid-In Capital(Or Share Stock) |
1,215,237,535.00 |
| Capital Surplus |
12,614,004,952.59 |
| Surplus Reserve |
346,250,578.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,427,274,635.02 |
| Minority Stockholder's Interest |
874,488,912.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,565,291,498.62 |
| Owner's Equity（Stockholder's Equity） |
18,439,780,410.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,500,331,603.64 |
